3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Paraparesis, Tropical Spastic
1
Neuritis
1
Leukemia-Lymphoma, Adult T-Cell
1
HTLV-I Infections
1
Interventions
mogamulizumab
3
Lenalidomide
2
Gemcitabine
2
peginterferon alfa-2b
1
liposomal doxorubicin
1
dolutegravir
1
denileukin diftitox
1
belinostat
1
Zidovudine
1
Tenofovir
1
Taxes
1
Panobinostat
1
Paclitaxel
1
Oxaliplatin
1
Lomustine
1
Irinotecan
1
Introns
1
Doxorubicin
1
Dexamethasone
1
Cytarabine
1
Cyclophosphamide
1
Cisplatin
1
Carboplatin
1
Calcium Dobesilate
1
Alemtuzumab
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Leukemia-Lymphoma, Adult T-Cell
×
Tenofovir
×
Clear all
NCT07555431
2026-06-02
DOT-H
Fundação Bahiana de Infectologia
Phase 2
Recruiting
146 enrolled